Prognostic impact of nectin-like molecule-5 (CD155) expression in non-small cell lung cancer.

Popa-Navarro XitlallyAvilés-Salas AlejandroHernández-Pedro NormaOrozco-Morales MarioCaballé-Pérez EnriqueCastillo-Ruiz CesarLucio-Lozada JoséBarrios-Bernal PedroHernandez-Martinez Juan-ManuelArrieta Oscar

Published in: Journal of translational medicine (2024)

is a predictor of worse outcomes in patients with advanced NSCLC, predominantly among those without oncogenic alterations. CD155 could be a potential biomarker and a molecular target in patients with poor responses to current therapies.

Keyphrases

small cell lung cancer
poor prognosis
nk cells
transcription factor
metabolic syndrome
african american
skeletal muscle
insulin resistance
weight loss
epidermal growth factor receptor